Loading insider details...
Beta
Latest Form 4 (May 22, 2026): Grant/Award of 67,000 TCRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Apr 23, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 33,900 | n/a |
| Nov 7, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 33,900 | n/a |
| Jul 2, 2025 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Jun 4, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 22,500 | n/a |
| Sep 18, 2024 | G1 Therapeutics, Inc. (GTHX) | Disposition to Issuer | 20,000 | n/a |
| Jun 14, 2024 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 47,500 | n/a |
| Jun 14, 2024 | G1 Therapeutics, Inc. (GTHX) | Grant/Award | 10,000 | n/a |
| May 28, 2024 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 32,335 | n/a |
| Jun 26, 2023 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 37,500 | n/a |